This page shows the latest PhRMA news and features for those working in and with pharma, biotech and healthcare.
Pharma industry executives have already criticised the orders, including Pharmaceutical Research and Manufacturers of America ( PhRMA) president and CEO, Stephen Ubl, who said: “The research-based biopharmaceutical industry has been working
Industry body PhRMA also hit back at the Democrat’s pricing plan, saying in a statement that it “would end the current market-based system that has made the US the
Alzheimer's, ALS and cancer, without hope for the treatments and cures they need," said Stephen Ubl, CEO of PhRMA.
Industry body PhRMA said in a statement that the Democrat plan “would end the current market-based system that has made the US the global leader in developing innovative, life-saving
PhRMA's Stephen Ubl. “The administration’s importation scheme is far too dangerous for American patients. ... PhRMA had been in support of proposals to ban the current system of rebate payments from pharma to PBMs, but this plan was recently
PME: A number of stakeholders say that EFPIA’s opposition to the SPC Waiver was disproportionate, and influenced by US pharma lobby groups such as PhRMA.
More from news
Approximately 7 fully matching, plus 134 partially matching documents found.
According to a PhrMA survey, industry invested $71.4bn in R&D in 2017, up from $29.8bn in 2001.
For the US market, this would formerly have been seen as an outrageous idea, and US pharma CEOs and industry lobby group PhRMA have opposed the move.
However, the Pharmaceutical Research and Manufacturers of America (PhRMA) said in a statement in February 2012 that it was 'highly concerned' that provisions regarding the reimbursement of innovative drugs and countering
Griffiths is a member of the EFPIA Board, chairwoman of the PhRMA Europe Committee, co-chairwoman of the EFPIA Executive Committee, a steering committee member of the J&J Women's
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Recently, she managed accounts for PhRMA and Johnson &Johnson. HRW. Joining HRW's leadership team is Sue Rees, who has been appointed as global director.
Fonteyne’s history has also seen him sit on the board of the Pharmaceutical Research and Manufacturers of America (PhRMA) industry association and has held various roles with Boehringer Ingelheim, Abbot
international health policy at Pharmaceutical Research and Manufacturers of America (PhRMA).
She is chair of the board of director at the iBIO Institute, and a member of the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Healthcare Business Women's Association
The appointment comes just days after Astellas announced the appointment of PhRMA's Karl Uhlendorf as communications and advocacy director.
More from appointments
Approximately 3 fully matching, plus 11 partially matching documents found.
Making diversity mandatory is a “no-brainer” for him and he emphasised that while, in November 2020, FDA (and subsequently PhRMA in November 2020) have released guidance in the United States,
However, with the FDA and PhRMA releasing new guidance it is likely we will start to see real change.
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. ... To address this, PhRMA will be committed to:. a.Enhancing education and diversity among clinical investigators.
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. ... The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021.
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
No results were found
90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...